Do Elevated Levels of Inflammatory Biomarkers Predict the Risk of Occurrence of Ischemic Stroke in SARS-CoV2 ?: An Observational Study
- 19 August 2021
- journal article
- research article
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (11) , 106063
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysisThrombosis Research, 2020
- Stroke in patients with SARS-CoV-2 infection: case seriesJournal of Neurology, 2020
- Large-Vessel Stroke as a Presenting Feature of Covid-19 in the YoungNew England Journal of Medicine, 2020
- Endothelial cell infection and endotheliitis in COVID-19The Lancet, 2020
- Characteristics of ischaemic stroke associated with COVID-19Journal of Neurology, Neurosurgery & Psychiatry, 2020
- Baseline Red Blood Cell Distribution Width as a Predictor of Stroke Occurrence and Outcome: A Comprehensive Meta-Analysis of 31 StudiesFrontiers in Neurology, 2019
- A Review of the JNC 8 Blood Pressure GuidelineTexas Heart Institute Journal, 2015
- A score to predict early risk of recurrence after ischemic strokeNeurology, 2010
- Homocysteine and vascular diseaseThe Lancet, 1999
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993